Economic impact of antimicrobial resistance.

• Type of Material: Article
• Authors: John E McGowan Jr., Emory University
• Language: English
• Date: 2001-03
• Publisher: U.S. National Center for Infectious Diseases
• Publication Version: Final Published Version
• Copyright Statement: Emerging Infectious Diseases is published by the Centers for Disease Control and Prevention, a U.S. Government agency. Therefore, all materials published in Emerging Infectious Diseases are in the public domain and can be used without permission.
• Final Published Version (URL): http://wwwnc.cdc.gov/eid/
• Title of Journal or Parent Work: Emerging Infectious Diseases
• ISSN: 1080-6040
• Volume: 7
• Issue: 2
• Start Page: 286
• End Page: 292
• Research Categories: Health Sciences, Health Care Management; Health Sciences, Epidemiology

Abstract

One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial-drug resistance is imprecise and incomplete. Studies to describe and evaluate the problem will have to employ new methods and be of large scale to produce information that is broadly applicable.